Doctor profile · Federal record
Dr. Frederick Dold, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Philadelphia, PA
- NPI 1174638597
- Accepts Medicare
- MIPS 90.5 / 100 · 2023
- 29 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3998 Red Lion RD, Suite 130
Philadelphia, PA 191141436
(215) 612-5250
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Pennsylvania #MD069519L
- Medicaid
- PA #0019378370001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174638597. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
78,578
Distinct HCPCS
10
Medicare allowed
$784,137
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 21,750 | 15 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,740 | 15 | $3 | |
J1453 |
Injection, fosaprepitant, 1 mg | 11,700 | 16 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 11,220 | 21 | $23 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 5,400 | 43 | $20 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,585 | 11 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,520 | 31 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 960 | 19 | $1 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 830 | 13 | $0 | |
Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 576 | 12 | $116 |
In context: peer comparison
Among 59 peers in Philadelphia Hematology & Oncology Physician, average services per provider: 829. This provider delivers 95× the peer median.Open Payments
Industry payments received
All-time total
$2,745
Transactions
74
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 7 | $234.40 | |
| Genzyme Corporation | 6 | $206.80 | |
| Abbvie INC. | 9 | $195.97 | |
| Novartis Pharmaceuticals Corporation | 10 | $170.26 | |
| AstraZeneca Pharmaceuticals Lp | 8 | $157.72 | |
| Incyte Corporation | 5 | $116.53 | |
| Merck Sharp & Dohme LLC | 5 | $115.87 | |
| Eisai INC. | 4 | $86.39 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $75.49 | |
| Bayer Healthcare Pharmaceuticals INC. | 3 | $72.52 | |
| Genentech USA, INC. | 3 | $70.37 | |
| Sobi, INC | 3 | $70.26 | |
| Lilly USA, LLC | 3 | $70.10 | |
| Karyopharm Therapeutics INC. | 3 | $64.49 | |
| Gilead Sciences, INC. | 2 | $64.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
388
Patients
56
Total drug cost
$519,621
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 58 | 17 | $2,536 |
| Xarelto (Rivaroxaban) | Brand | 44 | 0 | $27,701 |
| Eliquis (Apixaban) | Brand | 42 | 0 | $25,608 |
| Orgovyx (Relugolix) | Brand | 33 | 0 | $88,447 |
| Prochlorperazine Maleate | Generic | 32 | 25 | $368 |
| Lenalidomide | Generic | 29 | 0 | $371,376 |
| Levothyroxine Sodium | Generic | 22 | 0 | $365 |
| Ondansetron Hcl | Generic | 21 | 14 | $237 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 20 | 0 | $926 |
| Gabapentin | Generic | 16 | 0 | $969 |
Hospital affiliations
Frequently asked questions
What is Dr. Frederick Dold's medical specialty?
Dr. Frederick Dold practices Hematology & Oncology Physician in Philadelphia, PA.
Where does Dr. Frederick Dold practice?
Dr. Frederick Dold practices at 3998 Red Lion RD, Philadelphia, PA 191141436. Office phone: 2156125250.
What is Dr. Frederick Dold's NPI?
Dr. Frederick Dold's National Provider Identifier (NPI) is 1174638597, issued by NPPES.
Does Dr. Frederick Dold accept Medicare assignment?
Yes. Dr. Frederick Dold accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Frederick Dold commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.